Delivery Order SPE2DR25D3504-SPE2DR26F7CC0
- Not listed
- The Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $6,519.84 for TRIUMEQ 600-50-300 mg tablets in quantities of 30, with a firm fixed price contract type. The award was made on August 7, 2025, with an ultimate completion date of August 8, 2025, and represents a non-set-aside competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $16,855.22 on September 4, 2025, for the supply of Triumeq 600-50-300 mg tablets in quantities of 30 units. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be fulfilled from AmerisourceBergen's facility located in Conshohocken, Pennsylvania, with an ultimate completion date of September 5, 2025. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $6,870.93 on December 16, 2025, for the supply of Triumeq 600-50-300 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The contract completion date is set for December 17, 2025, with performance to occur at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $85,522.33 delivery order to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count units) on August 29, 2025, with an ultimate completion date of September 2, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of TRIUMEQ 600-50-300 mg tablets in quantities of 30s, with a ceiling value of $6,519.84 and an ultimate completion date of August 4, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,497.36, is for the delivery of Triumeq 600-50-300 mg tablets over a period ending on April 18, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,346.58 to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets in 30-unit packages. The contract is a non-set-aside, firm fixed price delivery order with an ultimate completion date of August 25, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $2,290.31 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count units) with a completion date of December 17, 2025. This competitively awarded contract, which carries no set-aside designation, supports federal pharmaceutical procurement needs with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $7,217.34 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 units of TRIUMEQ 600-50-300 mg tablets, with an ultimate completion date of September 24, 2025. This non-set-aside competitive award was issued on September 23, 2025, with performance to occur at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider serving as a critical vendor...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of the pharmaceutical distribution company AmerisourceBergen Corporation, for the provision of TRIUMEQ 600-50-300 MG tablets. The $15,507.76 contract has an ultimate completion date of November 18, 2021. AmerisourceBergen Drug Corp serves as the prime contractor on this delivery order, which is issued under an indefinite delivery contract (IDC) with a potential ceiling...
- SPE2DR25D3504Indefinite Delivery Contract
- SPE2DR25D3504-SPE2DR26F7CC0Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 6, 2026, for $11,316.77 to supply Triumeq 600-50-300 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under an open competition process. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of January 7, 2026. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), a major pharmaceutical distributor and healthcare solutions provider serving federal government agencies. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at up to $999,999,999.00 through December 2026. The parent company, Cencora, Inc., holds an even larger IDC with DLA valued at up to $999,999,999.00 through December 31, 2031. These vehicles enable the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including medications across multiple therapeutic domains, vaccines, syringes, vials, and test kits for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.3k | 1/5/26 |